scholarly journals Compliance of a cobalt chromium coronary stent alloy – the COVIS trial

Author(s):  
Jens Hagemeister ◽  
Frank M Baer ◽  
Robert HG Schwinger ◽  
Hans W Höpp
2005 ◽  
Vol 95 (1) ◽  
pp. 8-12 ◽  
Author(s):  
Michael H. Sketch ◽  
Michael Ball ◽  
Barry Rutherford ◽  
Jeffrey J. Popma ◽  
Catherine Russell ◽  
...  

2012 ◽  
Vol 13 (6) ◽  
pp. 316-320 ◽  
Author(s):  
Paul Vermeersch ◽  
Yolande Appelman ◽  
Dieter Horstkotte ◽  
Gert Richardt ◽  
Jean Boland ◽  
...  

2014 ◽  
Vol 27 (5) ◽  
pp. 491-499 ◽  
Author(s):  
DIDIER CARRIE ◽  
VOLKER SCHÄCHINGER ◽  
GIAN BATTISTA DANZI ◽  
CARLOS MACAYA ◽  
UWE ZEYMER ◽  
...  

2011 ◽  
Vol 149 (2) ◽  
pp. 199-204 ◽  
Author(s):  
Gabriella Visconti ◽  
Amelia Focaccio ◽  
Davide Tavano ◽  
Flavio Airoldi ◽  
Carlo Briguori

2010 ◽  
Vol 6 (2) ◽  
pp. 78 ◽  
Author(s):  
Ashok Seth ◽  

Since the first reported use of percutaneous transluminal coronary angioplasty (PTCA), advances in the interventional cardiology arena have been fast-paced. Within the last 10 years, these developments have been exponential. Developers and clinicians are fast adapting from the learning curve awarded by the time-course of drug-eluting stent (DES) evolution. The BioMime™ sirolimus-eluting coronary stent is a new step towards a biomimicry concept. The stent is built on an ultra-low strut thickness (65µm) cobalt–chromium stent platform using an intelligent hybrid of close and open cells allowing for morphology-mediated expansion, and employs a well-known antiproliferative – sirolimus – that elutes from a biodegradable co-polymer formulation in 30 days and ensures high coating integrity and a low coating thickness of 2µm. The resultant stent demonstrated almost 100% endothelialisation at 30 days in pre-clinical models and 0% major adverse cardiac events (MACE) at six months in the primary efficacy and safety clinical study.


2003 ◽  
Vol 12 (6) ◽  
pp. 50
Author(s):  
D.J. Kereiakes ◽  
D.A. Cox ◽  
J.B. Hermiller

Sign in / Sign up

Export Citation Format

Share Document